Riskpilot← Back to searchSign inGet full accessDuodens Oy
OYActiveY-tunnus 3327216-8Ratavartijankatu 4Manufacture of medical and dental instruments and supplies · NACE 3250Est. 20224 employees
Revenue 2024
EUR 308K
-35% vs 2023
EBITDA margin
1.7%
-87% vs 2023
Equity ratio
25.3%
Financial strength
Net profit 2024
EUR -2K
-107% vs 2023
| Revenue | EUR 308K | -35% |
| EBITDA | EUR 5K | -87% |
| Net profit | EUR -2K | -107% |
| Total assets | EUR 110K | -18% |
| Equity | EUR 28K | -7% |
| Employees | 4 | — |
Legal name
Duodens Oy
Y-tunnus number
3327216-8
Legal form
Osakeyhtiö
NACE code
3250 · Manufacture of medical and dental instruments and supplies
Founded
23. marraskuuta 2022
Share capital
EUR 0
Employees
4 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Company purpose
Yhtiön toimiala on hammasproteesien, keinohampaiden ym. valmistus, sekä alaan liittyvien aineiden ja tarvikkeiden maahantuonti ja myynti. Yhtiö voi myös omistaa ja käydä kauppaa kiinteistöillä ja arvopapereilla sekä harjoittaa kaikkea laillista liiketoimintaa.
Address
Ratavartijankatu 4
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2023 | 2024 |
|---|---|---|
| Revenue | 472 | 308 |
| Staff expenses | −190 | −129 |
| EBITDA | 43 | 5 |
| Depreciation & amort. | −2 | −1 |
| EBIT | 41 | 4 |
| Net financials | −4 | −6 |
| Profit before tax | 38 | −2 |
| Tax | 8 | −0 |
| Net profit | 30 | −2 |
| Item | 2023 | 2024 |
|---|---|---|
| Total assets | 134 | 110 |
| Equity | 30 | 28 |
| Long-term debt | 0 | 14 |
| Short-term debt | 104 | 68 |
| Total debt | 104 | 82 |
EBITDA margin
1.7%
This company
15.8%
Market median
-89% vs market
20232024
Equity ratio
25.3%
This company
38.2%
Market median
-34% vs market
20232024
Return on equity
-7.2%
This company
18.4%
Market median
-139% vs market
20232024
Net profit margin
-0.7%
This company
8.1%
Market median
-109% vs market
20232024
Asset turnover
2.80×
This company
1.12×
Market median
+150% vs market
20232024
Debt / equity
2.95×
This company
0.62×
Market median
-376% vs market
20232024
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
SC Deputy Member | Deputy Member | 2026 |
TK Audit | Audit | 2026 |
IJ Chief Executive Officer | Chief Executive Officer | 2022 |
PP Deputy auditor | Deputy auditor | 2026 |
| Former (1) | ||
RA Deputy Member | Deputy Member | 2022 – 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Board of Directors | 2026 | |
| Former (2) | ||
| Board of Directors | 2025 – 2026 | |
| Chairperson | 2022 – 2025 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Duodens Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Samu Christian Lindholm | Deputy Member | 0 companies |
| Timo Kalevi Packalén | Audit | 0 companies |
| Isa Josefina Lindholm | Chief Executive Officer | 0 companies |
| Pekka Patrik Packalén | Deputy auditor | 0 companies |
| Roope Antero Routaneva | Deputy Member | 0 companies |
| Joni Pekka Lybeck | Board of Directors | 0 companies |
| Sanna-Kaisa Marjatta Lindholm | Board of Directors | 0 companies |
| Sami Johannes Lehti | Chairperson | 0 companies |